Spagnoletti, Gionata
 Distribuzione geografica
Continente #
NA - Nord America 1.740
EU - Europa 1.247
AS - Asia 368
AF - Africa 56
OC - Oceania 9
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.432
Nazione #
US - Stati Uniti d'America 1.727
DE - Germania 328
SE - Svezia 287
IT - Italia 214
CN - Cina 139
UA - Ucraina 107
SG - Singapore 100
IE - Irlanda 85
ID - Indonesia 57
FR - Francia 56
CI - Costa d'Avorio 53
FI - Finlandia 37
GB - Regno Unito 32
IN - India 32
RU - Federazione Russa 30
PL - Polonia 24
IR - Iran 18
BE - Belgio 11
ES - Italia 11
AU - Australia 9
CA - Canada 7
BR - Brasile 6
JP - Giappone 5
MX - Messico 5
NL - Olanda 5
AT - Austria 4
SI - Slovenia 4
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HK - Hong Kong 3
PT - Portogallo 3
TR - Turchia 3
VN - Vietnam 3
CY - Cipro 2
EU - Europa 2
NO - Norvegia 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
BZ - Belize 1
DK - Danimarca 1
HU - Ungheria 1
KR - Corea 1
MD - Moldavia 1
MN - Mongolia 1
Totale 3.432
Città #
Chandler 479
Ashburn 149
Dublin 84
San Mateo 76
Milan 74
New York 73
Ann Arbor 64
Singapore 64
Wilmington 61
Jakarta 57
Abidjan 53
Jacksonville 52
Rome 43
Boston 39
Fairfield 39
Redwood City 37
Princeton 33
Dearborn 26
Moscow 24
Nanjing 23
Beijing 22
Warsaw 20
Lawrence 19
Nürnberg 18
Houston 17
Woodbridge 16
Los Angeles 15
Augusta 12
Marseille 12
Andover 11
Brussels 11
Hangzhou 11
Helsinki 11
Boardman 10
Nanchang 10
Zhengzhou 10
Seattle 9
Hebei 8
Shenyang 8
Bremen 7
Redmond 7
Costa Mesa 6
Lancaster 6
Pune 6
São Paulo 6
Washington 6
Cambridge 5
Cattolica 5
Fremont 5
Guangzhou 5
Kish 5
Norwalk 5
Tokyo 5
Bologna 4
Mexico 4
Mountain View 4
Romainville 4
San Diego 4
San Francisco 4
Shanghai 4
Tianjin 4
University Park 4
Amsterdam 3
Bangalore 3
Brno 3
Busto Arsizio 3
Changsha 3
Jiaxing 3
Kraków 3
Leawood 3
London 3
Munich 3
Parma 3
Santa Clara 3
Sydney 3
Vienna 3
Wuhan 3
Acquaviva delle Fonti 2
Ardabil 2
Bolzano 2
Changchun 2
Groningen 2
Haikou 2
Hanoi 2
Hong Kong 2
Izola 2
Jinan 2
Kochi 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Las Vegas 2
Ljubljana 2
Lomazzo 2
Martinsicuro 2
Monmouth Junction 2
Montreal 2
Nicosia 2
Oslo 2
Phoenix 2
Totale 2.006
Nome #
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 139
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 116
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 115
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 115
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 109
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 98
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 91
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 90
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 90
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 90
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 86
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 86
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 83
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 83
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 82
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 78
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 77
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 73
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 71
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 70
Evolution of causes of mortality in renal transplantation in the last 10 years 69
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 68
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 67
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 66
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 64
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 64
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 62
Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy 61
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 61
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 59
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 59
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 57
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 56
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 54
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 53
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 52
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 51
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early (vs delayed) introduction of everolimus in De Novo Kidney transplant recipients, with a follow-up evaluation at 12 months after transplant (NEVERWOUND study) 49
Thymoglobuline plus basiliximab a mixed cocktail to start? 49
Metabolic syndrome and cardiovascular disease in kidney transplantation 48
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 46
Radiofrequency thermal ablation of renal graft neoplasms: Case series and literature review 46
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 46
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy 41
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy 39
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 38
High-dose atorvastatin reduces oxidative stress of ischemia/reperfusion injury after isogeneic kidney transplantation in rats: in vivo, preclinical, case–control, open-label study 36
Long-Term Clinical Impact of Vesicoureteral Reflux in Kidney Transplantation 35
Severe silent myocardial ischemia during echocardiographic examination in a patient during cardiac screening for a kidney transplant intervention 35
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure 34
Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up 29
Elderly kidney transplant recipient with intermittent fever: A case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy 17
Induction With Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study 16
Risk of Kaposi Sarcoma after Solid-Organ Transplantation: Multicenter Study in 4767 Recipients in Italy, 1970-2006 12
Systematic use of magnetic double J stent in pediatric kidney transplantation: A single-center experience 3
Neurologic outcome following liver transplantation for methylmalonic aciduria 3
Case report: Pylorus-preserving pancreatoduodenectomy for focal congenital hyperinsulinism in a 5-month-old baby 3
Totale 3.490
Categoria #
all - tutte 15.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.309


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020240 0 0 19 3 6 11 29 4 23 9 78 58
2020/2021394 36 32 15 32 55 33 38 10 46 14 72 11
2021/2022504 36 29 11 16 19 19 16 86 20 36 101 115
2022/20231.170 149 169 68 209 57 146 73 96 157 5 24 17
2023/2024471 29 126 11 51 22 87 24 24 5 14 32 46
2024/2025197 28 53 116 0 0 0 0 0 0 0 0 0
Totale 3.490